saxy4u Posted - 18 hours ago

$PFE $MRK $RHHBY $BMY who is going to buy $ONCY ??? Major data is coming, in 90 exclusivity with Pfizer, should be released soon! Canadian biotech way under radar!

cctranscripts Posted - 3 days ago

Major owner of Roche Holding Ltd just disposed of 75,000 shares https://www.conferencecalltranscripts.org/summary/?id=11730452 $RHHBY

STCKPRO Posted - 4 days ago

$RHHBY NEW ARTICLE : Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant https://www.stck.pro/news/RHHBY/41413811

cctranscripts Posted - 4 days ago

Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant https://conferencecalltranscripts.com/summary/?id=489328&pr=true $RHHBY

Stock_Titan Posted - 4 days ago

$RHHBY Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant https://www.stocktitan.net/news/RHHBY/roche-launches-covid-19-pcr-test-to-detect-the-fast-spreading-xbb-1-bm1kjnfao9qu.html #covid19

Alberto1976 Posted - 5 days ago

"Among healthcare stocks, Eagle Pharmaceuticals is an interesting opportunity to benefit from volatility in stock markets. [...]" primary ticker: $egrx secondary tickers: $biib $rhhbf $RHHBY continue reading the article here: https://seekingalpha.com/article/4572186-eagle-pharmaceuticals-upside-could-be-lying-ahead-very-nicely?v=1674653582#comment-94313650

snosrap Posted - 5 days ago

$LCTX $PTCT had a $RHHBY deal too with milestones. Not a straight line just looking for some crumbs https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-announces-first-commercial-milestone-payment

6Wallstreet9 Posted - 6 days ago

$IBIO Seems like PR today. Wondering if our Ibio-101 data is still better than expected against $RHHBY data acquisition. Or maybe the CDMO Facility has been divested to push our incredible oncology pipeline forward with patented AI technology everyone's interested in. Dr. Martin Brenner has successfully demonstrated antibody work at $PFNX and surprise suprise...both $IBIO and them are in San Diego. Good luck everyone

BusinessInAudio Posted - 1 week ago

How To Calculate Intrinsic Value (Full Example) https://www.audea.io/audea?id=WL3n7TWtqrM $PFE $JNJ $NVS $ABT $LLY $CVS $UNH $TDOC $CRSP $RHHBY

ne8 Posted - 1 week ago

$ALLR Foundation Medicine (FMI) is a genomic testing company that was acquired by Roche ($RHHBY, $43.43, Not Rated) in 2018 in a $2.4B deal. Genomic Health is a genomic test diagnostic company acquired by Exact Sciences ($EXAS, $49.86, Not Rated) in 2019 in a $2.8B deal. Those companies did Ladenburg Thalmann compare with Allarity. These were acquired in 2018-2019 for their genomics technology to identify various diseases: ”The HCC registrational trial for dovitinib may be performed as the Simon two-stage design trial with a prespecified ORR and some 67% DRP score. However, the HCC trial is likely the strategy of $ALLR once RCC trial is up and running or if/when $ALLR is acquired by a larger biopharma player.” https://s28.q4cdn.com/241540924/files/ALLR-initiation-report-5.27.22.pdf

nlrmandate Posted - 1 week ago

$TGTX hey $MRK $SNY may want to consider buying $TGTX….Ubli has some significant advantages over Ocrevus and TG may well be able to take substantial market share from $RHHBY’s Ocrevus

STCKPRO Posted - 1 week ago

$RHHBY NEW ARTICLE : [Ad hoc announcement pursuant to Art. 53 LR] Roche's Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial https://www.stck.pro/news/RHHBY/41044564

otcdynamics Posted - 1 week ago

$RHHBY Genentech’s Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial https://www.otcdynamics.com/rhhby-genentechs-tecentriq-plus-avastin-is-the-first-treatment-combination-to-reduce-the-risk-of-cancer-returning-in-people-with-certain-types-of-early-stage-liver-cancer-in-a-phase-iii-tria

STCKPRO Posted - 1 week ago

$RHHBY NEW ARTICLE : Genentech's Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial https://www.stck.pro/news/RHHBY/41044723

cctranscripts Posted - 1 week ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial https://conferencecalltranscripts.com/summary/?id=485135&pr=true $RHHBY

Stock_Titan Posted - 1 week ago

$RHHBY [Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial https://www.stocktitan.net/news/RHHBY/ad-hoc-announcement-pursuant-to-art-53-lr-roche-s-tecentriq-plus-epn71znamt5j.html #cancer

STCKPRO Posted - 1 week ago

$RHHBY NEW ARTICLE : Relay Therapeutics: Tall Claims, Some Proofs Of Concept, Some Concerns https://www.stck.pro/news/RHHBY/41034387

MarketBeat Posted - 1 week ago

Roche downgraded by Deutsche Bank Aktiengesellschaft to sell. www.marketbeat.com/stocks/OTCMKTS/RHHBY/price-target/ $RHHBY

greatwhiteshark Posted - 1 week ago

$LCTX $RHHBY added Cincinnati Eye Institute as recruiting location for the upcoming OpRegen trial in the January 16th update: https://clinicaltrials.gov/ct2/history/NCT05626114?A=2&B=3&C=Side-by-Side#StudyPageTop

ObeCalp Posted - 1 week ago

$RHHBY Wish Roche had options to buy. Volume has been interesting of late.

stocksaudio1 Posted - 1 week ago

How To Calculate Intrinsic Value (Full Example) https://www.audea.io/audea?id=WL3n7TWtqrM $PFE $JNJ $NVS $ABT $LLY $CVS $UNH $TDOC $CRSP $RHHBY

BuBleRunner Posted - 2 weeks ago

$TEVA $PFE $nov $BNTX $RHHBY

Young_Antarian Posted - 2 weeks ago

$INFI partner BO could be $BMY or $RHHBY

STCKPRO Posted - 2 weeks ago

$RHHBY NEW ARTICLE : Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above https://www.stck.pro/news/RHHBY/40667946

cctranscripts Posted - 2 weeks ago

Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above https://conferencecalltranscripts.com/summary/?id=481782&pr=true $RHHBY

Stock_Titan Posted - 2 weeks ago

$RHHBY Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above https://www.stocktitan.net/news/RHHBY/roche-announces-the-european-commission-approval-of-xofluza-for-the-hp4chp21hdko.html

clinician55 Posted - 2 weeks ago

$PACB Another similar type example, some might recall was Roche's $RHHBY acquisition of Foundation Medicine $FMI. Foundation Medicine's biggest asset was the data they'd collected on tumor mutations - through vast genetic sequencing. Roche bought them for that dataset, well an the business of sequencing tumors. A company like $GOOG is all about data mining and collection, so the strategic agreement between $PACB and $GOOG makes sense, but I'd wager Google takes that a step further at some point. Well I guess I sort have wagered that by purchasing $PACB stock. LOL.

STOCK6996 Posted - 2 weeks ago

$BJDX $RHHBY 🙏

stocksaudiocontent Posted - 2 weeks ago

Buffett: How To Turn Small Sums Of Money Into Large Ones https://www.audea.io/audea?id=YD_5kDMY1Nr $PFE $JNJ $NVS $ABT $LLY $CVS $UNH $TDOC $CRSP $RHHBY

GOODluck19 Posted - 2 weeks ago

$SONN ah so they have a treatment that theyre working on with $RHHBY and $JNJ and one cant hold for a few months ? oiiiiii dum dums